Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection

Steven L. Flamm (Northwestern University) (Creator)
Jens Kort (Creator)
Steven E. Marx (Creator)
John Strezewski (Creator)
Douglas E. Dylla (Creator)
Bruce R. Bacon (Creator)
Michael P. Curry (Creator)
Naoky Tsai (Contributor)
Nicole Wick (Creator)

Dataset

1 Article

1 results

2020
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection
Flamm, S. L., Kort, J., Marx, S. E., Strezewski, J., Dylla, D. E., Bacon, B., Curry, M. P., Tsai, N. & Wick, N., May 1 2020, In: Advances in Therapy. 37, 5, p. 2267-2274 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
16 Scopus citations